Filing Details
- Accession Number:
- 0001593968-19-002186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-20 17:47:10
- Reporting Period:
- 2019-11-18
- Accepted Time:
- 2019-11-20 17:47:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887247 | Adamis Pharmaceuticals Corp | ADMP | Pharmaceutical Preparations (2834) | 820429727 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1461753 | J. David Marguglio | C/O Adamis Pharmaceuticals Corporation 11682 El Camino Real, Ste 300 San Diego CA 92130- | Svp And Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-11-18 | 8,283 | $0.87 | 365,307 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,884 | Indirect | By D. Marguglio as custodian for children |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted in March 2019.
- The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.